| |
Odds ratio (95% confidence interval)
|
|---|
|
Total
|
P
|
|---|
|
Crude
|
0.966 (0.954–0.978)
|
<0.001
|
|
Model 1
|
0.983 (0.969–0.997)
|
0.015
|
|
Model 2
|
0.961 (0.946–0.977)
|
<0.001
|
|
Model 3
|
0.959 (0.940–0.979)
|
<0.001
|
|
Model 4
|
0.956 (0.937–0.976)
|
<0.001
|
- Adiponectin 1 μg/mL increase, subgroup analysis was performed according to the cause of chronic kidney disease
- Model 1: adjusted for age, sex, smoking status, and body mass index
- Model 2: adjusted for model 1 + hemoglobin, serum albumin, uric acid, and phosphate
- Model 3: adjusted for model 2 + hs-CRP, urinary albumin-to-creatinine ratio, and eGFR
- Model 4: adjusted for model 3 + coronary artery disease, cerebrovascular disease, ARB, diuretics, statin, ezetimibe, and fibrate
-
DM diabetes mellitus, hs-CRP high sensitivity C-reactive protein, eGFR estimated glomerular filtration rate, ARB angiotensin II receptor blocker
